"Sloth makes all things difficult, but industry all easy; and he that riseth late must trot all day, and shall scarce overtake his business at night; while laziness travels so slowly, that poverty soon overtakes him.”? Benjamin Franklin
Karyopharm Therapeutics (KPTI) reported Q3 results Monday morning. It was a rock-solid report that has the shares up some six percent in trading yesterday, a nice way to kick off a new trading week. Below we highlight some of the key milestones contained within the quarter's accomplishments and update our investment thesis on this